Infections of synthetic vascular grafts are undoub tedly the most severe complications in vascular surgery and despite the continuous advancement of the medical science, the results of treatment of such complications have not improved. The percentage of amputations and deaths among these patients continues to remain at a high level, reaching 20-30% (Samson et al., 1988) . The risk of an infection of a graft in aortofemoral sec tion has been described as 0.5-3% (Swain et al., 2004) and it is extremely closely related to the place of implan tation. The likelihood of a graft infection is moreover increased by a number of factors such as extended time of an operation, the presence of different catheters and drains, intra and postoperative chyle leak, coexisting infections, immunodeficiency conditions, advanced age, malnourishment, diabetes mellitus or chronic immunosuppression. The lack of observance to the principles of aseptic techniques also has an impact.
The most common etiological factors are Staphylococcus strains which are responsible for more than 53% of all aortofemoral infections. They produce gly cocalyx, which on the one hand allows adhesion to the graft surface and on the other constitutes a component of biofilm providing protection against phagocytosis, antibodies and antibiotics (Bandyk et al., 1991) . Gram positive cocci of Enterococcus sp. cause an infection to a much lesser extent in grafts in the aortofemoral location. Several decades ago they were considered relatively pathogenic -little virulence and minor per centage of infections combined with their common occurrence in a human environment. The wide imple mentation of cephalosporins, to which Enterocci has a natural resistance, has led to their domination in gastrointestinal microbiota, which resulted in a higher rate of severe infections caused by these bacteria among hospitalized patients. Moreover, longterm application of a combination of penicillin and high concentrations of aminoglycosides in treatment of endocarditis caused by enterococci has led to the formation of HLAR strains. In turn, the extensive use of vancomycin in hospital therapy (for prevention and treatment of MRSA infec tions) with time resulted in the evolution of VRE strains (with varying degrees of resistance to vancomycin and teicoplanin). Of course, there are other determinants that are responsible for the pathogenicity of entero cocci, including the ability to produce cytolysin (hemo lysin), gelatinases, a serine protease, collagen binding protein (Ace) and fibrinogen (SagA), aggregation sub stance (AS), the extracellular surface protein (Esp), the cell wall adhesin (protein Efa), peroxides, hyalu ronidase, lipoteichoic acid, DNase, lipase and polysac charide capsule. The presence of these factors results in the ability of adhesion, colonization of the graft's sur face and formation of protective biofilm. The dominant species among enterococci causing these infections are strains of Enterococcus faecalis, which comprise 70-80% of the strains (Bronk and Samet, 2008) .
A major dilemma faced by a surgeon in view of a vascular graft infection is the selection of treatment. Currently it is commonly agreed that the removal of the infected graft and a concurrent vascular reconstruc tion is the best method. While surgical removal of the infected graft does not raise concerns in most cases, the reconstruction stage is associated with the necessity of selecting the optimal location of the reconstructed vascular bed (extraanatomical bypass or in situ bypass graft) together with the material necessary for its for mation (autologous vessels, cadaver homograft, silver coated grafts or antibioticsoaked vascular grafts).
The authors also encountered the problems pre sented above based on the case of a 73yearold patient with a massive infection of a dacron aortobifemoral vascular graft. The patient was initially operated on due to symptomatic Leriche syndrome with ischemia of both lower extremities stage III°, according to the Fontaine's scale (20-30 m intermittent claudication, rest pain, especially severe at night). The patient received a 18/9 mm bifurcated dacron graft. The upper anasto mosis was performed with the aorta below the origin of the inferior mesenteric artery and the lower fixa tions on both sides over femoral arteries bifurcation. In the early postoperative period (day 8), a massive leak of serosanguineous fluid appeared from the wound located in the right groin, and afterwards also from the left groin. During the next days, the content leak ing from the wound gradually changed its character to purulent. Throughout the whole postoperative period the patient did not present any fever and inflam matory markers were not specific for massive infec tion (leukocytosis 7000-9500/mm 3 , CRP 33-37 mg%).
Microbiological examination of the wound in left groin detected E. faecalis HLAR. Abdominal and Pelvic Com puted Tomography revealed the presence of inflamma tory infiltrate around both branches of the graft and an abscess in the distal anastomosis area on the right side, with no evident signs of infection within the aortic seg ment of the graft. It was decided that the patient should be reoperated. During the operation a total lack of the ingrowth healing process of the primary graft and fea tures of infection (purulent fluid around the graft), also in the vicinity of the proximal anastomosis to the aorta, were noticed. Dacron prosthesis was entirely removed and replaced by a combined aortobifemoral graft con structed from biosynthetic vascular graft Omniflow II and two femoral veins harvested from the patient (Fig. 1-3) . To this end a straight section of the Omni flow II graft (8 mm in diameter and 20 cm in length) was cut intraoperatively into two equal parts and the walls were incised longitudinally (2-2,5 cm section). Afterwards the two parts were anastomosed with each other (side to side) in the previously mentioned inci sions to give a bifurcated prosthesis with size 16/8 mm. Then, reversed 18/19cmlong segments of both femo ral veins obtained from the patient were sutured to the branches of the graft (endtoend). The combined bio syntheticautologous prosthesis constructed that way was implanted in place of the removed aortobifemoral graft. In the first hours after surgery, acute ischemia of the left lower limb occurred in the course of throm bosis of the left branch of implanted bypass, which demanded surgical thrombectomy. Further hospitali zation proceeded without any significant complications and the patient was discharged from the hospital. It should be noted that throughout the entire period of the hospital treatment a constant antibiotic therapy was used, despite obtaining negative cultures from the fluid surrounding the aortic section of the removed graft (however pathogens such as E. faecalis, which are capable of creating bacterial biofilm coating implanted materials are very rarely detected in the inflammatory exudate). Control Computed Tomography Angiogra phy was performed 3 months after reoperation, which indicated complete regression of the inflammatory infiltrate described in the previous test and the pres ence of significant stenosis (80% on the right side and 85% on the left side) in anastomoses of the Omniflow II prosthesis with autological femoral veins. Due to the progressive symptoms of ischemia of both lower limbs related to the gradual progression of these lesions, the patient was qualified for a planned endovascular pro cedure. An effective angioplasty of both anastomoses of bioprosthesis with femoral veins was performed, complemented by bilateral implantation of stents. Satis factory hemodynamic effect and complete regression of reported symptoms were achieved. In the nearly 2year ambulatory followup the patient did not show any signs of recurrence of infection within the vascular sys tem or blood circulation disorders of the lower limbs. In spite of conviction of the need for complete removal of a vascular graft in case of infection, attempts of conservative treatment (antibiotic therapy) or sur gery limited to the direct focus of infection are still reported. This results from the oftenisolated nature of an infection and the relatively high risk of complica tions that may occur during the removal of a prosthesis and reconstruction of a vascular bed. The scope of these operations may involve the removal of necrotic tissues, evacuation of inflammatory fluid reservoirs, irrigation drainage, local antibiotic therapy, coverage of bare sec tions of prostheses with wellvascularized muscle lobes and in selected cases segmental resection of the infected part of the graft with the reconstruction of the defect. In the described case the infection involved the entire graft, therefore its total elimination was the only option. Another argument in favour of such a procedure was the fact that the infection was caused by intestinal bac teria (E. faecalis), as a full recovery in such cases can only be achieved through the complete elimination of artificial material (Seabroock,1990) . Because of the severe symptoms of ischemia of the lower limbs prior to the primary surgery, simultaneous vascular recon struction was necessary.
Revascularization at the site of infection, because of the high risk of reinfection of the new bypass, requires the implantation of biological material (autologous vessels or cadaver homograft) or synthetic grafts more resistant to infections (antibioticsoaked or impreg nated with silver). The latter are mainly used in the case of deficiency of the biological material. In fact, results obtained in recent years have shown in fact no antimicrobial activity of prostheses impregnated with silver and a high risk of their recurrent infection (Batt et al., 2008) . On the other hand, experimentally proven effectiveness of grafts coated with antibiotics to prevent intraoperative infections does not resolve doubts about their longterm antibacterial effect, resulting from the gradual progressive decrease of local concentration of antibiotics and increasing antibiotic resistance (Lew and Moore, 2011) . The use of homografts, with signifi cantly higher resistance to reinfections, is inextricably linked to their limited supply (requiring access to a tis sue bank), gradual degeneration (due to the immuno logical rejection reactions), and retrograde changes (which are a consequence of conservation by freezing), resulting in true aneurysms, spontaneous rupture of the graft wall, anastomotic bleeding and thrombotic com plications, as well as the risk of transmission of viral diseases (Verhelst et al., 2000) . Admittedly, the use of immunosuppression prolongs the proper functioning of allogeneic grafts, but requires continuous applica tion (Pupka et al., 2004) . A way to circumvent these problems may be the use of autologous femoral veins, which provide all of the benefits associated with the use of biological material (the least vulnerability to super infection, the ability to fully grow into a focus of infec tion) in the simultaneous absence of risks specific to the allografts (Dirven et al., 2015) . The disadvantages of this method include extended operation time and unfor tunately common disproportion between the available resource of veins and the length of the prosthesis, which they ought to replace. The first one loses its importance due to improvements in surgical technique (Budtz Lilly et al., 2014) , however to overcome the other, an additional source of material for the reconstruction of the vascular bed is required (with properties as close as possible to transplant tissue). The authors decided to use, as a supplement of the patient's femoral veins, a composite biosynthetic vascular graft Omniflow II. Its complex structure is created by a polyester mesh endoskeleton, which is the endurance element provid ing mechanical resistance and which is a kind of scaf folding for a biological component and the covering coating of ovine collagen allowing overgrowth of the graft wall by the vessels and tissues of the recipient.
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Omniflow's II high ability of incorporation into the host tissue has been known for over 20 years (Werkmeister et al., 1995) , which makes it an alternative to autolo gous material during the preparation of the vascular graft (Dünschede et al., 2015) or arteriovenous dialysis access (Palumbo et al., 2009) . Until recently, due to the lack of manufacturer's recommendations for Omniflow II implantation within the foci of infection, its use in the treatment of vascular graft infections was avoided. In 2012, Töpel et al., presented the first positive results of the use of these prostheses (in two cases combined with saphenous vein) for replacement of an infected graft located below the inguinal ligament (Töpel et al., 2012) . Other authors have arrived at similar findings Wiltberger et al., 2014) .
In 2014, Neufang took advantage of these biopros theses, combined with autologous superficial veins, to create vascular spans allowing to bypass longsegment obstructions of the arteries of the lower limbs. In the described cases, Omniflows II were the proximal parts of those spans (Neufang et al., 2014) . So far the only work devoted to reconstructions using Omniflow II grafts in the aortofemoral segment was published in 2015 (Krasznai et al., 2015) . Most authors highly evalu ated the bioprosthetic Omniflow II in terms of their resistance to reinfection and degenerative changes. Despite the high resistance to infection, the authors limited the scope of the use of the mentioned pros thesis to the proximal section of aortobifemoral graft only. This was due to the presence of purulent fistulas in both groins, which were the locations of distal anas tomoses. The authors concluded that the use of a bypass comprising even small amounts of synthetic material, in such conditions can cause a reinfection. The applied method of anatomical revascularization, using a combi nation of prosthesis Omniflow II with bilateral venous grafts allows the rational use of the existing stock of autologous vessels, as well as the simultaneous use of biosynthetic material in areas of reduced risk of infec tion. At the same time, however, it should be noticed that the combined character of the grafts carries the risk of potential stenoses in multiple anastomoses and requires regular clinical and radiological controls to provide their early identification.
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